Abbvie Inc

NYSE:ABBV   10:35:45 AM EDT
117.34
-0.85 (-0.72%)
Products

AbbVie Says Venetoclax Granted U.S. FDA Breakthrough Therapy Designation

Published: 07/21/2021 05:18 GMT
Abbvie Inc (ABBV) - Venetoclax (venclexta®) Granted U.S. FDA Breakthrough Therapy Designation (btd) in Higher Risk Myelodysplastic Syndrome (mds).